ClouDr Group Limited (FRA:H3L)

Market Cap	34.94M -70.9%
Revenue (ttm)	197.65M -53.5%
Net Income	-112.53M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0400
Previous Close	0.0505
Day's Range	0.0400 - 0.0400
52-Week Range	0.0365 - 0.1860
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About ClouDr Group

ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company’s integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and to help enhance the doctor education; chronic condition management solution to hospitals, including hospital SaaS and ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2014
• Employees: 887
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: H3L

Financial Performance

In 2025, ClouDr Group's revenue was 1.62 billion, a decrease of -53.47% compared to the previous year's 3.49 billion. Losses were -924.15 million, 79.0% more than in 2024.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error